Proteomics analysis of the peritoneal dialysate effluent reveals the presence of calciumregulation proteins and acute inflammatory response

Clinical Proteomics

Volumn 11, Issue 1, 2014, Pages

  Oliveira, Elisabete ^a,b   Araújo, José E ^a,b   Gómez Meire, Silvana ^c   Lodeiro, Carlos ^a,b   Perez Melon, Cristina ^d   Iglesias Lamas, Elena ^d   Otero Glez, Alfonso ^d   Capelo, José L ^a,b   Santos, Hugo M ^a,b  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b ProteoMass Scientific Society Madan Parque   (Portugal)

^c UNIVERSITY OF VIGO   (Spain)

^d Servicio Gallego de Salud   (Spain)

Author keywords

2D gel electrophoresis; Peritoneal dialysis effluent; Protein identification; Proteomics

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN; APOLIPOPROTEIN 4; APOLIPOPROTEIN A1; BETA2 GLYCOPROTEIN; CALCIUM; CERULOPLASMIN; COMPLEMENT FACTOR D; CYSTATHIONINE BETA SYNTHASE; DITHIOTHREITOL; FETUIN A; FIBRINOGEN; FIBRINOGEN BETA CHAIN; FIBRINOGEN GAMMA CHAIN; GLYCOPROTEIN; HAPTOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G GAMMA 1 CHAIN C; IMMUNOGLOBULIN G KAPPA CHAIN C REGION; OROSOMUCOID; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN AMBP; PROTEIN PHOSPHATASE 1D; PROTEOME; RETINOL BINDING PROTEIN 4; SEROTRANSFERRIN; TRANSFERRIN; UNCLASSIFIED DRUG; ZINC ALPHA 2 GLYCOPROTEIN;

ADULT; AGED; ARTICLE; CALCIUM METABOLISM; CLINICAL ARTICLE; DIALYSATE; FEMALE; HUMAN; INFLAMMATION; KIDNEY INJURY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REGULATORY MECHANISM; SOFT TISSUE CALCIFICATION; TANDEM MASS SPECTROMETRY;

EID: 84903776579     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-11-17     Document Type: Article

References (36)

1. Brewis IA, Topley N: Proteomics and peritoneal dialysis: early days but clear potential. Nephrol Dial Transplant 2010, 25:1749-1753.
2. Anderson NL, Anderson NG: The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867.
3. Muller GA, Muller CA, Dihazi H: Clinical Proteomics - on the long way from bench to bed side? Nephrol Dial Transplant 2007, 22:297-1300.
4. Thongboonkerd V: Current status of renal and urinary proteomics: ready for routine clinical application? Nephrol Dial Transplant 2010, 25:11-16.
5. Ferrero S, Gillott DJ, Remorgida V, Anserini P, Leung KY, Ragin N, Grudzinskas JG: Proteomic analysis of peritoneal fluid in women with endometriosis. J Proteome Res 2007, 6:3402-3411. (Pubitemid 47522730)
6. Tyan Y, Liao P: Proteomics analysis of serous fluid and effusions: pleural, pericardial and peritoneal. Proteomics Clin Appl 2007, 1:834-844.
7. Liotta LA, Kristensen GB, Troppé CG, Berner A, Kohn EC, Davidson B, Espina V, Steinberg SM, Flørenes VA: Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res 2006, 12:791-799. (Pubitemid 43259859)
8. Stegmayr BG: A survey of blood purification techniques. Transfus Apher Sci 2005, 32:209-220. (Pubitemid 40387374)
9. Ghahramani N, Shadrou S, Hollenbeak C: A systematic review of continous renal replacement therapy and intermittent hemodialysis in management of patients with acute renal failure. Nephrology 2008, 13:570-578.
10. Kimmel PL, Patel SS: Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Semin Nephrol 2006, 26:68-79. (Pubitemid 43075516)
11. Murata GH, Tzamaloukas AH, Raj DS, Onime A, Servilla KS, Vanderjagt DJ: The prescription of peritoneal dialysis. Semin Dial 2008, 21:250-257.
12. Bouchard J, Khosla N, Mehta RL: Emerging therapies for extracorporeal support. Nephron Physiol 2008, 109:85-91.
13. Heimburger O, Lindholm B, Pecoits-Filho R, Stenvinkel P, Wang AY: Chronic inflammation in peritoneal dialysis: The search for the holy grail. Perit Dial Int 2004, 24:327-339. (Pubitemid 39206627)
14. Reddingius RE, Schroder CH, Daha MR, Willems HL, Koster AM, Monnens LA: Complement in serum and dialysate in children on continuous ambulatory peritoneal dialysis. Perit Dial Int 1995, 15:49-53.
15. Saku K, Sasaki J, Naito S, Arakawa K: Lipoprotein and apolipoprotein losses during continuous ambulatory peritoneal dialysis. Nephron 1989, 51:220-224. (Pubitemid 19037696)
16. Van Der Kamp HJ, Otten BJ, Swinkels LM, Sweep CG, Monnens LA, Schroder CH: Influence of peritoneal loss of GHBP, IGFBP-3 on serum levels in children with ESRD. Nephrol Dial Transplant 1999, 14:257-258. (Pubitemid 29041928)
17. Twardowski ZJ: Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 1989, 7:95-108. (Pubitemid 19115542)
18. Righetti PG, Castagna A, Antonioli P, Boschetti E: Prefractionation techniques in proteome analysis: The mining tools of the third millennium. Electrophoresis 2005, 26:297-319. (Pubitemid 40253785)
19. Roche S, Tiers L, Provansal M, Seveno M, Piva MT, Jouin P, Lehmann S: Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: The more the better? J Proteomics 2009, 72:945-951.
20. Fernández C, Santos HM, Ruíz-Romero C, Blanco FJ, Capelo-Martínez JL: A comparison of depletion versus equalization for reducing highabundance proteins in human serum. Electrophoresis 2011, 32:2966-2974.
21. Warder SE, Tucker LA, Strelitzer TJ, McKeegan EM, Meuth JL, Jung PM, Saraf A, Singh B, Lai-Zhang J, Gagne G, Rogers JC: Reducing agent-mediated precipitation of high-Abundance plasma proteins. Anal Biochem 2009, 387:184-193.
22. Kerrien S, Aranda B, Breuza L, Bridge A, Broackes-Carter F, Chen C, Duesbury M, Dumousseau M, Feuermann M, Hinz U, Jandrasits C, Jimenez RC, Khadake J, Mahadevan U, Masson P, Pedruzzi I, Pfeiffenberger E, Porras P, Raghunath A, Roechert B, Orchard S, Hermjakob H: The IntAct molecular interaction database in 2012. Nucleic Acids Res 2012, 40:D841-846.
23. Maere S: BiNGO: A cytoscape plugin to access overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 2:521-539.
24. Heiss A, Eckert T, Aretz A, Richtering W, van Drop W, Jahnen-Dechen W, Richtering W, van Drop W, Jahnen-Dechen W: Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J Biol Chem 2008, 283:14815-25.
25. Jahnen-Dechent W, Schäfer C, Ketteler M, McKee MD: Mineral chaperones: A role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 2008, 86:379-89.
26. Heinrichsdorff J, Olefsky JM: Fetuin-A: The missing link in lipid-induced inflammation. Nat Med 2012, 18:1182-1183.
27. Ketteler M, Jahnen-Dechent W, Westenfeld R, Schäfer C, Smeets R, Brandenburg MV, Floege J: Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant 2007, 22:1537-1546. (Pubitemid 47073751)
28. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, JahnenDechent W: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003, 112:357-366. (Pubitemid 38063764)
29. Kyle RA, Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR: Serum reference intervals and diagnostic ranges for free κ and free λ immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002, 48:1437-1444. (Pubitemid 34925779)
30. Olsson MG, Allhorn M, Bülow L, Hansson SR, Ley D, Olsson ML, Schmidtchen A, Akerstrom B: Pathological conditions involving extracellular hemoglobin: molecular mechanisms, clinical significance, and novel therapeutic opportunities for α1-microglobulin. Antiox Redox Signal 2012, 17:813-846.
31. Acharya SS, Dimichele DM: Rare inherited disorders of fibrinogen. Haemophilia 2008, 14:1151-1158.
32. Lang T, Johanning K, Metzler H, Piepenbrock S, Solomon C, Rahe-Meyer N, Tanaka KA: The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009, 108:751-758.
33. Sritippayawan S, Chiangjong W, Semangoen T, Aiyasanon N, Jaetanawanitch P, Sinchaikul S, Chen ST, Vasuvattakul S, Thongboonkerd V: Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes. J Proteome Res 2007, 6:4356-4362. (Pubitemid 350158511)
34. Tyan YC, Su SB, Ting SS, Wang HY, Liao PC: A comparative proteomics analysis of peritoneal dialysate before and after the occurrence of peritonitis episode by mass spectrometry. Clin Chim Acta 2013, 420:34-44.
35. Wang HY, Lin CY, Chien CC, Kan WC, Tian YF, Liao PC, Wu HS, Su SB: Impact of uremic environment on peritoneum: A proteomic view. J Proteomics 2012, 75:2053-2063.
36. Wang HY, Tian YF, Chien CC, Kan WC, Liao PV, Wu HY, Su SB, Lin CY: Differential proteomic characterization between normal peritoneal fluid and diabetic peritoneal dialysate. Nephrol Dial Transplant 2010, 25:1955-1963.